Bacteremia due to Campylobacter species: clinical findings and antimicrobial susceptibility patterns

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
C PigrauA Pahissa

Abstract

From 1979 to 1996, 58 patients (mean age, 39.4 years) were treated for bacteremia due to Campylobacter species at the Hospitals Vall d'Hebron in Barcelona, Spain. Bacteremia was considered to be hospital acquired in 30% of these patients. Almost all the patients (93%) had underlying conditions; liver cirrhosis was the most frequent (34% of patients), and neoplasia, immunosuppressive therapy, and human immunodeficiency virus disease were also common. Of the 58 Campylobacter strains isolated, 81% were C. jejuni, 10% were Campylobacter species, 7% were C. fetus, and one (2%) was C. coli. Resistance rates were: cephalothin, 82%; co-trimoxazole, 79%; quinolones, 54%; ampicillin, 20%; amoxicillin/clavulanate, 4%; erythromycin, 7%; gentamicin, 0; and tetracyclines, 0. Even though the majority of patients were immunocompromised, mortality was low (10.5%), and only one patient relapsed. Because of the high level of resistance to the quinolones in Campylobacter species, these drugs should not be used as empirical treatment, at least in Spain. Although the macrolides remain the antibiotics of choice, amoxicillin/clavulanate may be an effective alternative therapy.

Citations

Apr 26, 2007·Folia Microbiologica·O KopeckýR Parízková
Nov 14, 2007·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·L GazaigneP Lesprit
Jan 5, 2000·Microbes and Infection·T M Wassenaar, M J Blaser
Oct 26, 2011·Nature Reviews. Gastroenterology & Hepatology·Si Ming Man
Sep 13, 2002·Pediatrics International : Official Journal of the Japan Pediatric Society·Tomoharu AkibaNatsume Yazaki
Mar 7, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·T F WolfsJ A Wagenaar
Aug 14, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jérôme PacanowskiUNKNOWN CAMPYL Study Group
Sep 17, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Benjamin FeodoroffHilpi Rautelin
Jun 15, 2004·The Pediatric Infectious Disease Journal·Koichi TokudaMasao Yoshinaga
Jan 19, 2012·The Pediatric Infectious Disease Journal·Holly NadorlikAsuncion Mejias
Sep 24, 2011·Journal of Clinical Microbiology·Sander DinantJuliëtte A Severin
May 18, 2007·Journal of Clinical Microbiology·Jean-Winoc DecousserFrancis Megraud
Aug 9, 2003·Journal of Clinical Microbiology·José LlovoAurora Fernández-Astorga
Nov 1, 2008·BMC Infectious Diseases·Ji-Rong YangJung-Jung Mu
Feb 6, 2010·Annals of Clinical Microbiology and Antimicrobials·Xavier LemaireEric Senneville
Nov 8, 2003·Pediatric Research·Ellen CrushellBilly Bourke
Jan 18, 2006·Internal Medicine·Keiko WachiKou Uchida
Mar 19, 2014·Médecine et maladies infectieuses·A CypierreP Weinbreck
Sep 2, 2014·Internal Medicine·Takehiko MoriSatoshi Iwata
Nov 23, 2013·European Journal of Microbiology & Immunology·Markus M HeimesaatStefan Bereswill
Mar 1, 2012·European Journal of Microbiology & Immunology·H SprengerG Gorkiewicz
Mar 1, 2012·European Journal of Microbiology & Immunology·R LouwenH P Endtz
Jul 4, 2003·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Olivier VandenbergJean-Paul Butzler
Jun 21, 2016·Infectious Diseases·Khetam HusseinImad Kassis
Dec 1, 2002·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Mark S Pasternack
Nov 4, 2000·Pediatrics International : Official Journal of the Japan Pediatric Society·M KanekoN Nakano
Jun 12, 2009·Critical Reviews in Microbiology·Arie H HavelaarDiane G Newell
Jun 13, 2015·Clinical Microbiology Reviews·Nadeem O KaakoushSi Ming Man
May 11, 2016·Antimicrobial Agents and Chemotherapy·Juan Aguilar-CompanyBenito Almirante
Feb 6, 1999·The American Journal of Gastroenterology·T L JacksonT M McCashland
May 19, 2007·The American Journal of Gastroenterology·Leonidas ChristouMatthew E Falagas
Aug 22, 2003·Journal of the American Veterinary Medical Association·Sean F Altekruse, Linda K Tollefson
Jun 5, 2012·World Journal of Hepatology·Chalermrat Bunchorntavakul, Disaya Chavalitdhamrong

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Campylobacteriosis

Campylobacteriosis is caused by the bacteria Campylobacter jejuni and is a common cause of gastroenteritis in humans. Discover the latest research on Campylobacteriosis here.

Campylobacteriosis (ASM)

Campylobacteriosis is caused by the bacteria Campylobacter jejuni and is a common cause of gastroenteritis in humans. Discover the latest research on Campylobacteriosis here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Jérôme PacanowskiCAMPYL Study Group
Journal of Clinical Pathology
C Ladrón de GuevaraP Peña
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
L GazaigneP Lesprit
Pediatrics International : Official Journal of the Japan Pediatric Society
Tomoharu AkibaNatsume Yazaki
© 2021 Meta ULC. All rights reserved